Gut Microbiota‐Derived Bacterial Extracellular Vesicles in COVID‐19: Their Signature and Immunological Impact
Journal of Extracellular Vesicles · 2026-07 · 15 (7)
DOI: 10.1002/jev2.70341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 23.07.2026. Verfasst von Aya Ishizaka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, COVID-19, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS) KAKENHI, Taiju Life Social Welfare Foundation.
Abstract (Originalsprache)
Gut microbial dysbiosis has been observed in several diseases. Although causal links and direct effects on host cells remain unclear, bacteria‐derived extracellular vesicles (BEVs) from the gut microbiota may regulate the host immune response. We examined the impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection on the gut microbiome and BEVs release, and the effects of released BEVs on cytokine responses in monocyte‐derived cell lines. Fecal samples from 17 patients with coronavirus disease 2019 (COVID‐19) and 20 healthy individuals were collected to isolate bacterial and BEV fractions. Parental BEV‐releasing bacteria were identified from vesicle‐encapsulated bacterial DNA by 16S rRNA gene sequencing. Patients with COVID‐19 exhibited altered gut microbiota composition and the profile of bacterial DNA‐containing BEVs (dcBEVs) release compared to healthy controls. BEVs from patients, but not from healthy individuals, significantly changed cytokine levels in U937 monocyte cells. Following COVID‐19 recovery, dcBEV profiles diverged into two distinct groups: those that retained the capacity to induce cytokines in monocytes and those that lost this functionality. BEVs from single bacterial cultures within families altered after COVID‐19 onset affected the expression of genes in monocytes, primarily immune‐response genes, notably chemokine ligands and G protein‐coupled receptors. SARS‐CoV‐2–induced dysbiosis alters the profile of dcBEVs release, thereby modulating the host immune response and potentially contributing to COVID‐19 pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of the Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo, Tokyo, Japan.
- Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Taketoshi Mizutani
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Japan Society for the Promotion of Science (JSPS) KAKENHI
- Taiju Life Social Welfare Foundation
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- OTC Self-Medication Promotion Foundation
- Yamaguchi memorial
Zitieren
APA
Ishizaka, A., Koga, M., Hayashi, T., Ishii, K. J., Yamamoto, H., Yotsuyanagi, H., & Mizutani, T. (2026). Gut Microbiota‐Derived Bacterial Extracellular Vesicles in COVID‐19: Their Signature and Immunological Impact. Journal of Extracellular Vesicles, 15(7). https://doi.org/10.1002/jev2.70341
Vancouver
Ishizaka A, Koga M, Hayashi T, Ishii KJ, Yamamoto H, Yotsuyanagi H, et al. Gut Microbiota‐Derived Bacterial Extracellular Vesicles in COVID‐19: Their Signature and Immunological Impact. Journal of Extracellular Vesicles. 2026;15(7). doi:10.1002/jev2.70341
BibTeX
@article{Ishizaka2026,
author = {Ishizaka, Aya and Koga, Michiko and Hayashi, Tomoya and Ishii, Ken J and Yamamoto, Hiroyuki and Yotsuyanagi, Hiroshi and Mizutani, Taketoshi},
title = {Gut Microbiota‐Derived Bacterial Extracellular Vesicles in COVID‐19: Their Signature and Immunological Impact},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {7},
doi = {10.1002/jev2.70341}
}
EUVIMED